Related references
Note: Only part of the references are listed.In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
Jiachun Su et al.
MICROBIAL DRUG RESISTANCE (2019)
Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection
Victor Band et al.
NATURE MICROBIOLOGY (2019)
Economic burden of inpatients infected with Klebsiella pneumoniae carbapenemase
Wendel Mombaque dos Santos et al.
EINSTEIN-SAO PAULO (2019)
Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL- and KPC-producing Enterobacter cloacae
Brandon Kulengowski et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection
Victor I. Band et al.
MBIO (2018)
Molecular characterization and epidemiology of carbapenem non- susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China
Xue Gong et al.
BMC INFECTIOUS DISEASES (2018)
In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae
Wenzhi Huang et al.
CLINICAL INFECTIOUS DISEASES (2018)
An overview of the antimicrobial resistance mechanisms of bacteria
Wanda C. Reygaert
AIMS MICROBIOLOGY (2018)
Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains
P. Morici et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Prevalence and genetic characteristics of carbapenem-resistant Enterobacteriaceae strains in China
Rong Zhang et al.
LANCET INFECTIOUS DISEASES (2017)
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
Hajo Grundmann et al.
LANCET INFECTIOUS DISEASES (2017)
The Potential of Systems Biology to Discover Antibacterial Mechanisms of Plant Phenolics
Caroline S. Rempe et al.
FRONTIERS IN MICROBIOLOGY (2017)
Comparative Analysis of the Bacterial Membrane Disruption Effect of Two Natural Plant Antimicrobial Peptides
Attila Farkas et al.
Frontiers in Microbiology (2017)
Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
Gabrielle A. Gibson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yi-Yun Liu et al.
LANCET INFECTIOUS DISEASES (2016)
Colistin Resistance Mechanisms in Klebsiella pneumoniae Strains from Taiwan
Yi-Hsiang Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria
Kwang-sun Kim et al.
JOURNAL OF ANTIBIOTICS (2015)
Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
Zhiliang Yu et al.
BIOMED RESEARCH INTERNATIONAL (2015)
In Vitro Activities of Combinations of Rifampin with Other Antimicrobials against Multidrug-Resistant Acinetobacter baumannii
Yan Bai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes
Sushim Kumar Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments
T. Tangden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin
Antonio Cannatelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study
Abiola Olumuyiwa Olaitan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing
Christopher D. Doern
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
Georgios Meletis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli
Aixin Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Polymyxin B: similarities to and differences from colistin (polymyxin E)
Andrea Kwa et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa
Joseph B. McPhee et al.
JOURNAL OF BACTERIOLOGY (2006)
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
PJ Petersen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium
JS Gunn et al.
INFECTION AND IMMUNITY (2000)
Share Paper
